OSM promotes epithelial to mesenchymal transition (EMT) of cancer stem cell (CSC) properties by activating Stat3/TGF-β/SMAD3 signaling, and therefore, promotes tumor metastasis and tumor recurrence [41]. Here, STAT3 is linked to cancer.